LEALING BIOPHARMA
LIVE

Serial Number

90860167

Owner

Liling biopharmaceuticals (Suzhou) Co., Ltd

First Use Date

Jul 31, 2021

Filing Date

Aug 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LEALING BIOPHARMA Trademark

Serial Number: 90860167 • Registration: 6825724

LEALING BIOPHARMA is a trademark filed by Liling biopharmaceuticals (Suzhou) Co., Ltd on August 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Liling biopharmaceuticals (Suzhou) Co., Ltd (5 trademarks)

Room 502, Building 1, Shunda Commercial
Jiangsu 215000 , CN

Entity Type: 99

Trademark Details

Filing Date

August 2, 2021

Registration Date

August 23, 2022

First Use Anywhere

July 31, 2021

First Use in Commerce

July 31, 2021

Published for Opposition

June 7, 2022

Goods & Services

Immunostimulants; Biological preparations for the treatment of cancer; Biological preparations for the treatment of infectious diseases; Disinfecting wipes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Jan 11, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jan 11, 2025 WOAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2022 CNEA
ASSIGNED TO EXAMINER
Apr 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2021 NWOS
NEW APPLICATION ENTERED
Aug 5, 2021 NWAP